39.83 USD
▲+0.32+1.89%
盘后 39.09 0.00%
2026-08-03
市值
$1.48B
市盈率
—
EPS
-0.40
股息率
—
52 周区间
28.54 – 54.85
成交量
368.33K
Beta
0.25
目标价
67.75
52W 低 28.5452W 高 54.85
价格走势
公司简介
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for p...